VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.8900
-0.0504 (-5.36%)
At close: Jun 20, 2025, 4:00 PM
0.9016
+0.0116 (1.30%)
After-hours: Jun 20, 2025, 6:14 PM EDT
VYNE Therapeutics Stock Forecast
VYNE's stock price has decreased by -59.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover VYNE Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $6.25, which forecasts a 602.25% increase in the stock price over the next year. The lowest target is $4.5 and the highest is $8.
Price Target: $6.25 (+602.25%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 25, 2025.
Analyst Ratings
The average analyst rating for VYNE Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.75 → $4.5 | Strong Buy | Maintains | $5.75 → $4.5 | +405.62% | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +546.07% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +546.07% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +546.07% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +546.07% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
714.00K
from 501.00K
Increased by 42.51%
Revenue Next Year
459.00K
from 714.00K
Decreased by -35.71%
EPS This Year
-1.08
from -0.94
EPS Next Year
-0.75
from -1.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 840,000 | 945,000 | n/a | |
| Avg | 714,000 | 459,000 | n/a | |
| Low | 588,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 67.7% | 32.4% | - | |
| Avg | 42.5% | -35.7% | - | |
| Low | 17.4% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.87 | -0.62 | -0.67 |
| Avg | -1.08 | -0.75 | -0.65 |
| Low | -1.32 | -0.86 | -0.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.